Alivus Life Sciences Limited (BOM: 543322)

Alivus Life Sciences Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 19, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Market Capitalization	124,163	95,161	48,141	56,215	-	-
Market Cap Growth	71.12%	97.67%	-14.36%	-	-	-
Enterprise Value	119,859	90,913	44,570	52,405	-	-
Last Close Price	1012.55	775.30	378.46	410.94	-	-
PE Ratio	29.32	20.21	10.31	13.43	-	-
PS Ratio	5.88	4.17	2.23	2.65	-	-
PB Ratio	5.10	4.08	2.25	2.74	-	-
P/TBV Ratio	5.14	4.11	2.27	2.75	-	-
P/FCF Ratio	48.90	33.44	33.62	12.08	-	-
P/OCF Ratio	31.08	23.01	15.73	9.41	-	-
EV/Sales Ratio	5.44	3.98	2.06	2.47	-	-
EV/EBITDA Ratio	19.79	13.59	6.97	8.53	-	-
EV/EBIT Ratio	21.71	14.61	7.42	9.05	-	-
EV/FCF Ratio	45.23	31.95	31.12	11.26	-	-
Debt / Equity Ratio	0.01	0.01	0.01	0.00	1.24	2.64
Debt / EBITDA Ratio	0.03	0.03	0.03	0.00	1.57	2.24
Debt / FCF Ratio	0.06	0.06	0.14	0.01	2.91	7.36
Asset Turnover	0.73	0.82	0.84	0.95	1.01	0.96
Inventory Turnover	1.52	1.64	1.87	2.07	2.02	1.76
Quick Ratio	2.81	2.64	2.34	3.10	0.66	0.52
Current Ratio	4.52	4.37	3.73	4.60	1.15	0.89
Return on Equity (ROE)	17.18%	21.07%	22.28%	29.83%	60.91%	127.84%
Return on Assets (ROA)	11.43%	14.01%	14.52%	16.20%	18.86%	17.33%
Return on Capital (ROIC)	13.90%	17.25%	17.82%	19.33%	22.32%	20.46%
Earnings Yield	3.40%	4.95%	9.70%	7.45%	-	-
FCF Yield	2.05%	2.99%	2.97%	8.28%	-	-
Dividend Yield	0.00%	2.90%	5.55%	5.11%	-	-
Payout Ratio	65.10%	58.55%	82.64%	30.73%	-	-
Buyback Yield / Dilution	-0.28%	-0.13%	-4.25%	-9.02%	-	-35.79%
Total Shareholder Return	-0.28%	2.78%	1.30%	-3.91%	-	-35.79%

Source: S&P Capital IQ. Standard template. Financial Sources.